Does VALGANCICLOVIR Cause Cytomegalovirus infection reactivation? 374 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 374 reports of Cytomegalovirus infection reactivation have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 4.7% of all adverse event reports for VALGANCICLOVIR.
374
Reports of Cytomegalovirus infection reactivation with VALGANCICLOVIR
4.7%
of all VALGANCICLOVIR reports
109
Deaths
155
Hospitalizations
How Dangerous Is Cytomegalovirus infection reactivation From VALGANCICLOVIR?
Of the 374 reports, 109 (29.1%) resulted in death, 155 (41.4%) required hospitalization, and 52 (13.9%) were considered life-threatening.
Is Cytomegalovirus infection reactivation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 374 reports have been filed with the FAERS database.
What Other Side Effects Does VALGANCICLOVIR Cause?
Off label use (1,882)
Cytomegalovirus infection (1,091)
Drug ineffective (886)
Neutropenia (809)
Leukopenia (574)
Drug resistance (524)
Cytomegalovirus viraemia (447)
Pancytopenia (434)
Death (359)
Acute kidney injury (336)
What Other Drugs Cause Cytomegalovirus infection reactivation?
MYCOPHENOLATE MOFETIL (1,071)
CYCLOPHOSPHAMIDE (1,065)
TACROLIMUS (980)
CYCLOSPORINE (950)
FLUDARABINE (917)
RITUXIMAB (683)
METHOTREXATE (572)
METHYLPREDNISOLONE (520)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (484)
BUSULFAN (481)
Which VALGANCICLOVIR Alternatives Have Lower Cytomegalovirus infection reactivation Risk?
VALGANCICLOVIR vs VALIUM
VALGANCICLOVIR vs VALPROATE
VALGANCICLOVIR vs VALPROIC ACID
VALGANCICLOVIR vs VALPROMIDE
VALGANCICLOVIR vs VALSARTAN